E2F5 and pancreatic adenocarcinoma: In the Grutzmann dataset (42), the expression of E2F5/7/8 was significantly increased in PAAD, with fold changes of 1.603 (P = 0.009), 4.181 (P = 7.70E-4), and 4.334 (P = 0.002), respectively.